The combined OR was 0.87 (95% CI: 0.37–2.03; Z = 0.33; P = 0.740), suggesting that ezrin immunoexpression was not associated with histological response of osteosarcoma patients (Figure 4). This evidence concerns the gene EZR and osteosarcoma.